I have immersed myself in the tech world for over five years, focusing my efforts on providing readers with in-depth reviews of gadgets. Exploring the ins and outs of the latest tech has been quite a ...
JASCAYD 18 mg showed a nominally significant reduction in the risk of acute ILD exacerbations over the blinded trial duration (up to 109 weeks) compared to placebo (HR 0.60 [95% CI: 0.38, 0.94]). 5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback